Effect of apolipoprotein E genotype on hippocampal volume loss in aging healthy women

Objective: To determine whether the presence of a single ε4 allele of the APOE gene is associated with an increased rate of hippocampal volume loss or decline in cognition in healthy women in their sixth decade of life. Methods: Nine APOE-ε4 allele–negative (mean age ± SD, 60.6 ± 10.2 years) and 16 APOE-ε4 allele–positive (mean age ± SD, 55.1 ± 6.0 years) healthy women underwent neurocognitive testing and MRI at the time of entry into the study (baseline) and 2 years later. Neurocognitive testing consisted of the Buschke-Fuld Free Recall, verbal fluency tests, the Rey Figure Test, the Wechsler Memory Scale–Revised, and the Wechsler Adult Intelligence Survey–Revised Block Design. Hippocampal volume determinations were based on manual outlining of sagittal slices aided by axial, coronal, and three-dimensional views of high-resolution 124-slice whole-brain scans; the scans were obtained with a 1.5-tesla scanner using a T1-weighted three-dimensional gradient echo sequence with RF spoiling (TR/TE/flip angle, 24 msec/3 msec/30 °). Results: The percent change in hippocampal volume per year was greater in the APOE-ε4 allele–positive group (mean ± SD, 2.32 ± 1.75%) than in the APOE-ε4 allele–negative group (mean ± SD, 0.77 ± 1.02%; t = 2.41; p < 0.03, two-tailed test). There were no significant differences between the two groups in terms of any of the cognitive measures, and hippocampal volume loss was not correlated with changes in any of the above-mentioned cognitive measures. Conclusions: The presence of a single APOE-ε4 allele is associated with an increased rate of hippocampal volume loss in healthy women in their sixth decade of life that is not related to any detectable memory changes.

[1]  Cees Jonker,et al.  Medial temporal lobe atrophy and memory dysfunction as predictors for dementia in subjects with mild cognitive impairment , 1999, Journal of Neurology.

[2]  Gene E. Alexander,et al.  Volumes of Medial Temporal Lobe Structures in Patients with Alzheimer’s Disease and Mild Cognitive Impairment (and in Healthy Controls) , 1998, Biological Psychiatry.

[3]  B. Hyman,et al.  Apolipoprotein E and cognitive change in an elderly population , 1996, Annals of neurology.

[4]  M. Lucero,et al.  Calcium Signalling in Squid Olfactory Receptor Neurons , 1999, Neurosignals.

[5]  H. Soininen,et al.  Volumes of hippocampus, amygdala and frontal lobes in the MRI-based diagnosis of early Alzheimer's disease: Correlation with memory functions , 1995, Journal of neural transmission. Parkinson's disease and dementia section.

[6]  P. Falkai,et al.  Amygdala-hippocampal atrophy and memory performance in dementia of Alzheimer type. , 1997, Dementia and geriatric cognitive disorders.

[7]  Allan L. Reiss,et al.  Reliability and validity of MRI measurement of the amygdala and hippocampus in children with fragile X syndrome , 1997, Psychiatry Research: Neuroimaging.

[8]  J. Haines,et al.  Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease: A Meta-analysis , 1997 .

[9]  H. Wiśniewski,et al.  In Vivo Structural Studies of the Hippocampus in Normal Aging and in Incipient Alzheimer's Disease a , 1996, Annals of the New York Academy of Sciences.

[10]  W. Jagust,et al.  Quantitative NMR measurements of hippocampal atrophy in Alzheimer's disease , 1988, Magnetic resonance in medicine.

[11]  J. Lindeboom,et al.  Association between apolipoprotein E ε4 and the rate of cognitive decline in community-dwelling elderly individuals with and without dementia , 1998 .

[12]  Herman Buschke,et al.  Selective reminding for analysis of memory and learning , 1973 .

[13]  M. Rossor,et al.  The earliest cognitive change in a person with familial Alzheimer's disease: presymptomatic neuropsychological features in a pedigree with familial Alzheimer's disease confirmed at necropsy. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[14]  J. Haines,et al.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. , 1997, JAMA.

[15]  D. Salmon,et al.  Neuropsychological features of memory disorders in Alzheimer disease. , 1994 .

[16]  J. Cauley,et al.  Apolipoprotein E phenotype and cognitive decline in a prospective study of elderly community women. , 1997, Archives of neurology.

[17]  Arthur L. Benton,et al.  Word fluency and brain damage , 1967 .

[18]  D P Salmon,et al.  Regional cerebral volume loss associated with verbal learning and memory in dementia of the Alzheimer type. , 1999, Neuropsychology.

[19]  E M Wijsman,et al.  Gender difference in apolipoprotein E-associated risk for familial Alzheimer disease: a possible clue to the higher incidence of Alzheimer disease in women. , 1996, American journal of human genetics.

[20]  C. Jack,et al.  Usefulness of MRI measures of entorhinal cortex versus hippocampus in AD , 2000, Neurology.

[21]  D. Wechsler Manual for the Wechsler Adult Intelligence Scale. , 1955 .

[22]  S Lehéricy,et al.  Memory disorders in probable Alzheimer's disease: the role of hippocampal atrophy as shown with MRI. , 1995, Journal of neurology, neurosurgery, and psychiatry.

[23]  Jonathan D. Smith Apolipoprotein E4: an allele associated with many diseases , 2000, Annals of medicine.

[24]  L R Schad,et al.  Quantitative magnetic resonance imaging and neuropsychological functions in dementia of the Alzheimer type , 1997, Psychological Medicine.

[25]  G. Alexander,et al.  Declining brain activity in cognitively normal apolipoprotein E ɛ4 heterozygotes: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[26]  L B Taylor,et al.  Localisation of cerebral lesions by psychological testing. , 1969, Clinical neurosurgery.

[27]  A. Nappi,et al.  Alzheimer ' s Disease : Cell-Specific Pathology Isolates the Hippocampal Formation , 2022 .

[28]  A. Convit,et al.  Specific Hippocampal Volume Reductions in Individuals at Risk for Alzheimer’s Disease , 1997, Neurobiology of Aging.

[29]  N Butters,et al.  Episodic memory changes are associated with the APOE- epsilon 4 allele in nondemented older adults , 1995, Neurology.

[30]  H. Soininen,et al.  Major decrease in the volume of the entorhinal cortex in patients with Alzheimer’s disease carrying the apolipoprotein E ε4 allele , 1998, Journal of neurology, neurosurgery, and psychiatry.

[31]  R. Dukoff,et al.  Quantitative assessment of apolipoprotein E genotypes by image analysis of PCR-RFLP fragments. , 2000, Clinica chimica acta; international journal of clinical chemistry.

[32]  C. Jack,et al.  Memory and MRI-based hippocampal volumes in aging and AD , 2000, Neurology.

[33]  S Lehéricy,et al.  Amygdalohippocampal MR volume measurements in the early stages of Alzheimer disease. , 1994, AJNR. American journal of neuroradiology.

[34]  Margaret A. Pericak-Vance,et al.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease , 1997 .

[35]  Y. Agid,et al.  Apolipoprotein E ϵ4 Allele and Familial Aggregation of Alzheimer Disease , 1998 .

[36]  S. Resnick,et al.  Longitudinal change in hippocampal volume as a function of apolipoprotein E genotype , 2000, Neurology.

[37]  M. Roth,et al.  Observations on the brains of non-demented old people. , 1968, Journal of the neurological sciences.

[38]  Y. Agid,et al.  Apolipoprotein E epsilon4 allele and familial aggregation of Alzheimer disease. , 1998, Archives of neurology.

[39]  J. Greene Contributions to Neuropsychological Assessment , 1995 .

[40]  O Nalcioglu,et al.  Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer's disease , 1991, Neurology.

[41]  Charles DeCarli,et al.  APOE-ε4 is associated with less frontal and more medial temporal lobe atrophy in AD , 1999, Neurology.

[42]  C. Finch,et al.  Evidence for an interaction between apolipoprotein E genotype, gender, and Alzheimer disease. , 1999, Alzheimer disease and associated disorders.

[43]  J. Mazziotta,et al.  Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[44]  J T O'Brien,et al.  Temporal lobe magnetic resonance imaging can differentiate Alzheimer's disease from normal ageing, depression, vascular dementia and other causes of cognitive impairment , 1997, Psychological Medicine.

[45]  C. Jack,et al.  MR‐based hippocampal volumetry in the diagnosis of Alzheimer's disease , 1992, Neurology.

[46]  H. Soininen,et al.  Comparative MR analysis of the entorhinal cortex and hippocampus in diagnosing Alzheimer disease. , 1999, AJNR. American journal of neuroradiology.

[47]  M. Albert,et al.  Temporal lobe regions on magnetic resonance imaging identify patients with early Alzheimer's disease. , 1993, Archives of neurology.

[48]  Alistair Burns,et al.  Observations on the brains of demented old people. B.E. Tomlinson, G. Blessed and M. Roth, Journal of the Neurological Sciences (1970) 11, 205–242; (1968) 7, 331–356 , 1997 .

[49]  C. Jack,et al.  Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease , 1998, Neurology.

[50]  E G Tangalos,et al.  Hippocampal atrophy and apolipoprotein E genotype are independently associated with Alzheimer's disease , 1998, Annals of neurology.

[51]  Nick C Fox,et al.  Presymptomatic hippocampal atrophy in Alzheimer's disease. A longitudinal MRI study. , 1996, Brain : a journal of neurology.

[52]  A D Roses,et al.  Apolipoprotein E alleles as risk factors in Alzheimer's disease. , 1996, Annual review of medicine.